Servier Drug Patent Portfolio
Servier owns 2 orange book drugs protected by 14 US patents Given below is the list of Servier's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10980788 | Therapy for treating malignancies | 07 Jun, 2039 | Active |
| US11345677 | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | 16 Jan, 2039 | Active |
| US10653710 | Combination therapy for treating malignancies | 18 Oct, 2036 | Active |
| US11844758 | Therapeutically active compounds and their methods of use | 04 Dec, 2035 | Active |
| US10449184 | Pharmaceutical compositions of therapeutically active compounds | 13 Mar, 2035 | Active |
| US10799490 | Pharmaceutical compositions of therapeutically active compounds | 13 Mar, 2035 | Active |
| US9968595 | Pharmaceutical compositions of therapeutically active compounds | 13 Mar, 2035 | Active |
| US10172864 | Therapeutically active compounds and their methods of use | 11 Jul, 2034 | Active |
| US9579324 | Therapeutically active compounds and their methods of use | 11 Jul, 2034 | Active |
| US9474779 | Therapeutically active compositions and their methods of use | 19 Aug, 2033 | Active |
| US10717764 | Therapeutically active compounds and their methods of use | 18 Jan, 2033 | Active |
| US11667673 | Therapeutically active compounds and their methods of use | 18 Jan, 2033 | Active |
| US9850277 | Therapeutically active compositions and their methods of use | 18 Jan, 2033 | Active |
| US10610125 | Methods and compositions for cell-proliferation-related disorders | 21 Jun, 2030 | Active |
Latest Legal Activities on Servier's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Servier.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 25 Apr, 2024 | US9474779 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 Jan, 2024 | US10717764 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Nov, 2023 | US10653710 |
|
Electronic Review
Critical
| 06 Jun, 2023 | US11667673 |
| Mail Patent eGrant Notification | 06 Jun, 2023 | US11667673 |
| Recordation of Patent eGrant | 06 Jun, 2023 | US11667673 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 06 Jun, 2023 | US11667673 |
|
Recordation of Patent Grant Mailed
Critical
| 06 Jun, 2023 | US11667673 |
|
Email Notification
Critical
| 06 Jun, 2023 | US11667673 |
| Patent eGrant Notification | 06 Jun, 2023 | US11667673 |
|
Electronic Review
Critical
| 18 May, 2023 | US11667673 |
|
Email Notification
Critical
| 18 May, 2023 | US11667673 |
|
Issue Notification Mailed
Critical
| 17 May, 2023 | US11667673 |
| Dispatch to FDC | 25 Apr, 2023 | US11667673 |
|
Application Is Considered Ready for Issue
Critical
| 25 Apr, 2023 | US11667673 |
Servier's Drug Patent Litigations
Servier's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Aug 15, 2022, against patent number US10610125. The petitioner Rigel Pharmaceuticals, Inc., challenged the validity of this patent, with Servier Pharmaceuticals LLC et al. as the respondent. Click below to track the latest information on how companies are challenging Servier's patents.
| Patent | Proceeding Filing Date | Status | Respondent | Petitioner |
|---|---|---|---|---|
 | ||||
| US10610125 | August, 2022 |
Terminated-Settled
(06 Jan, 2023)
| Servier Pharmaceuticals LLC et al. | Rigel Pharmaceuticals, Inc. |
Servier's Family Patents
Servier Drug List
Given below is the complete list of Servier's drugs and the patents protecting them.
1. Tibsovo
Tibsovo is protected by 10 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10980788 | Therapy for treating malignancies |
07 Jun, 2039
(14 years from now)
| Active |
| US10653710 | Combination therapy for treating malignancies |
18 Oct, 2036
(11 years from now)
| Active |
| US10449184 | Pharmaceutical compositions of therapeutically active compounds |
13 Mar, 2035
(9 years from now)
| Active |
| US10799490 | Pharmaceutical compositions of therapeutically active compounds |
13 Mar, 2035
(9 years from now)
| Active |
| US9968595 | Pharmaceutical compositions of therapeutically active compounds |
13 Mar, 2035
(9 years from now)
| Active |
| US9474779 | Therapeutically active compositions and their methods of use |
19 Aug, 2033
(8 years from now)
| Active |
| US10717764 | Therapeutically active compounds and their methods of use |
18 Jan, 2033
(7 years from now)
| Active |
| US11667673 | Therapeutically active compounds and their methods of use |
18 Jan, 2033
(7 years from now)
| Active |
| US9850277 | Therapeutically active compositions and their methods of use |
18 Jan, 2033
(7 years from now)
| Active |
| US10610125 | Methods and compositions for cell-proliferation-related disorders |
21 Jun, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tibsovo's drug page
2. Voranigo
Voranigo is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11345677 | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same |
16 Jan, 2039
(13 years from now)
| Active |
| US11844758 | Therapeutically active compounds and their methods of use |
04 Dec, 2035
(10 years from now)
| Active |
| US10172864 | Therapeutically active compounds and their methods of use |
11 Jul, 2034
(9 years from now)
| Active |
| US9579324 | Therapeutically active compounds and their methods of use |
11 Jul, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Voranigo's drug page